No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Seres Therapeutics Strengthens Future With VOWST Sale
TD Cowen Maintains Seres Therapeutics(MCRB.US) With Buy Rating
Seres Therapeutics (MCRB) Receives a Buy From TD Cowen
Seres Therapeutics Reports 'Positive Impact' in SER-155 Early Trial; Cash Runway Extended
Express News | Seres Therapeutics Inc - Ser-155 Shows Significant Decrease in Fecal Albumin and Systemic Inflammation
Express News | Seres Therapeutics Inc - Extends Cash Runway Into Q1 2026